Aloe Emodin Market, By Source (Aloes, Rheum Emodi, Candle Bush and Others), By Form (Solid, Liquid, Gels) By Application (Proteasome Inhibitors, Chromatography, Anti-inflammatory Agents, Others) By End Use Industry (Healthcare, Cosmetics, Textiles and Others) – Global Industry Insights, Trends and Forecast, 2017-2025

Created On: Aug-2018
Report ID: IR192
Format: PDF

Aloe Emodin Market: Introduction

Aloe Emodin are extracted from medicinal plants such as aloes, rheum emodi, and others which are used for the development of drugs for pharmaceutical purposes and also having its application in the phytochemicals market. There are various herbal plants from which aloe emodin is extracted such as R. emodi which is used in several applications such as curing skin diseases, for nephroprotective activity, used for textile dyeing, as a food colorant, and also as anti-inflammatory in cosmetics.

The aloe emodin market is expected to grow due to its anti-inflammatory reaction to the skin which helps to avoid skin burns, melanomas, and UV rays, coupled with its other properties such as skin toning, smoothing, anti-aging, moisturizing, and others. In recent discoveries, the U.S. Food and Drug Administration (FDA), approved the use of aloe emodin in antiseptic gels and in natural deodorants such as Spirit Nest, Alvera, and others. Aloe emodin is entering the cosmetics market which is expected to be over US$ 500 billion by 2025, due to changing consumer preference for organic products, which is in turn is expected to boost the aloe emodin market during the forecast period. Aloe emodin also acts as an anti-cancer agent. The extraction of aloe emodin from aloe vera leaves contains specific in-vivo and in-vitro anti-neuroectodermal tumor properties which helps to fight the neuroectodermal tumor cells through specific drug incorporation pathway.

Growth & Developments:

The aloe emodin market is expected to grow due to various driving factors such as active components such as anthroquinone that acts as an inhibitor for hemoglobin aggregation, as an anticancer agent against neuroectodermal tumors, and as an anti-oxidant in various cosmetics such as face-cream, shampoos, and others. Some of the other factors expected to drive the aloe emodin market during the forecast period is the growing prevalence of consumers towards herbal medicines and cosmetics. Various companies are coming up with drugs for tumor treatments which includes herbal products that uses aloe emodin. For instance, Aloin, of MacFarlan Smith Ltd. is a drug for the treatment of neuroectodermal tumors containing aloe emodin, another company which manufacturer drugs for neuroectodermal tumors using aloe emodin is Sigma-Aldrich Corporation. According to the National Center for Biotechnology Information (NCBI), aloe emodin has various biochemistry and pharmacology applications, such as it helps with inhibition of cell invasion, migration, and proliferation, induction of cell death, redox and mitochondrial membrane perturbations, and modulation of immune signaling in cancer cell lines. The aloe emodin acts as an anti-cancer agent due to anti-carcinogenic and multiple anti-proliferative properties. Such factors are expected to create new growth opportunities in the global aloe emodin market.

Regional Insights:

Europe is expected to dominate the aloe emodin market throughout the forecast period from 2018 to 2025, and Asia Pacific is expected to be the fastest growing in terms of CAGR. The Europe market in expected to be driven owing to its growth in sale of skin care products by 23%, according to the European Commission, in 2017. Other factors which is expected to boost the growth of aloe emobin market is its application as an anti-cancer agents, coupled with the increase in consumers preference for herbal medicines that has increased by 19% in 2017 compared to previous year. Aloe emodin does not show any cytotoxic activity against any normal cells which helps them to fight against leukemia cell lines thus making it a major herbal solution against leukemia treatment. In Europe, the average populous suffering from leukemia is 2 out 10, according to the European Commission, in 2017. Hence, increasing demand in the healthcare industry is further expected to drive the aloe emodin market.

Key Players

Major players operating in the aloe emodin market are Aloe Farms, Inc., MacFarlan Smith Ltd., Sigma-Aldrich Corporation, Evergreen, Terry Laboratories, and Shaanxi Yongyuan Bio-Tech Co., Ltd. among others.

Our Research Approach Includes
  •  Market Outlining
  •  Framing discussion guide
  •  Data Validation
  • Data Analysis
  •  Re-Validation and Finalization of Data
  •  Report Insights and Publishing
Our Research Approach Includes
  •  Market Outlining
  •  Framing discussion guide
  •  Data Validation
  • Data Analysis
  •  Re-Validation and Finalization of Data
  •  Report Insights and Publishing
Reach Out to us